AUTHOR=Marseille Elliot , Stauffer Christopher S. , Agrawal Manish , Thambi Paul , Roddy Kimberly , Mithoefer Michael , Bertozzi Stefano M. , Kahn James G. 

TITLE=Group psychedelic therapy: empirical estimates of cost-savings and improved access

JOURNAL=Frontiers in Psychiatry

VOLUME=Volume 14 - 2023

YEAR=2023

URL=https://www.frontiersin.org/journals/psychiatry/articles/10.3389/fpsyt.2023.1293243

DOI=10.3389/fpsyt.2023.1293243

ISSN=1664-0640

ABSTRACT=Objective: To compare group and individual psychedelic-assisted therapy in terms of clinician time, costs and patient access.Methods: Using 2023 data from two group therapy trial sites, one using 3,4-Methylenedioxy methamphetamine (MDMA) to treat posttraumatic stress disorder (PTSD), and one using psilocybin to treat major depressive disorder (MDD), we compared overall variable costs, clinician costs and clinician time required by therapy protocols utilizing groups versus individual patient therapy. Using published literature, we estimated the prevalence of adults with PTSD and MDD eligible for treatment with psychedelic therapy and projected the savings in time and cost required to treat these prevalent cases.